SEC Form 4 · accession 0001144204-17-064174
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles S. Ryan
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $7.55 | Dec 14, 2017 | A | 157,918 | A | — | Dec 14, 2027 | Common Stock | 157,918 | 157,918 | D |
Explanation of responses
- F1These securities were issued in connection with the Reporting Person's appointment as a director to the Issuer's board of directors.
- F2Half of the stock options shall vest upon grant, and the remaining stock options shall vest daily over the following four-year period.